Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Centrient Pharmaceuticals
Centrient Pharmaceuticals
Activities:
Ingredients
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
Centrient Pharmaceuticals announces Non-Executive Supervisory Board appointment
Manja Boerman is the President of Catalent Cell & Gene Therapy with overall responsibility for strategy and leadership of the cell and gene businesses
Manufacturing
Centrient begins production at second statins manufacturing unit
With the building now completed, the company will double its statins production capacity
Finance
Centrient to acquire Astral SteriTech
The acquisition is aimed to make Centrient a better integrated partner to generics marketers
Manufacturing
South Korea addresses AMR in manufacturing
Antimicrobial Resistance (AMR) has been addressed at Seoul conference as the government takes action
Subscribe now